Found: 35
Select item for more details and to access through your institution.
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.
- Published in:
- Technology in Cancer Research & Treatment, 2022, v. 21, p. 1, doi. 10.1177/15330338221128414
- By:
- Publication type:
- Article
Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 3, p. 2743, doi. 10.1007/s11033-022-08194-3
- By:
- Publication type:
- Article
Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. e856, doi. 10.1093/oncolo/oyac136
- By:
- Publication type:
- Article
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1008, doi. 10.1634/theoncologist.2017-0629
- By:
- Publication type:
- Article
MET fusions are targetable genomic variants in the treatment of advanced malignancies.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-023-01454-0
- By:
- Publication type:
- Article
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01074-1
- By:
- Publication type:
- Article
The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 6539, doi. 10.2147/OTT.S176429
- By:
- Publication type:
- Article
Progress in the treatment of solid tumors with apatinib: a systematic review.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 4137, doi. 10.2147/OTT.S172305
- By:
- Publication type:
- Article
Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03434-1
- By:
- Publication type:
- Article
ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 962, doi. 10.1111/1759-7714.13817
- By:
- Publication type:
- Article
Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 9, p. 2736, doi. 10.1111/1759-7714.13583
- By:
- Publication type:
- Article
Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma.
- Published in:
- Oncology Letters, 2018, v. 16, n. 5, p. 5607, doi. 10.3892/ol.2018.9355
- By:
- Publication type:
- Article
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 5, p. 1019, doi. 10.1007/s13402-021-00616-x
- By:
- Publication type:
- Article
CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway.
- Published in:
- Oncology Reports, 2017, v. 37, n. 6, p. 3484, doi. 10.3892/or.2017.5602
- By:
- Publication type:
- Article
Isocorydine Inhibits Cell Proliferation in Hepatocellular Carcinoma Cell Lines by Inducing G2/M Cell Cycle Arrest and Apoptosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036808
- By:
- Publication type:
- Article
The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0937-4
- By:
- Publication type:
- Article
Neoadjuvant toripalimab plus platinum-paclitaxel chemotherapy in stage II-III non-small cell lung cancer: a single-center, single-arm, phase I study in China.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 1, p. 86, doi. 10.1007/s10637-022-01324-5
- By:
- Publication type:
- Article
Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00208-9
- By:
- Publication type:
- Article
Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00193-z
- By:
- Publication type:
- Article
The role of RICTOR amplification in targeted therapy and drug resistance.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-0146-6
- By:
- Publication type:
- Article
Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma.
- Published in:
- Chinese Journal of Lung Cancer, 2020, v. 23, n. 4, p. 239, doi. 10.3779/j.issn.1009-3419.2020.101.12
- By:
- Publication type:
- Article
RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02892-x
- By:
- Publication type:
- Article
Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
- Published in:
- Cancer Science, 2018, v. 109, n. 4, p. 1088, doi. 10.1111/cas.13518
- By:
- Publication type:
- Article
RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy.
- Published in:
- Journal of Gene Medicine, 2024, v. 26, n. 8, p. 1, doi. 10.1002/jgm.3729
- By:
- Publication type:
- Article
Role of YES1 signaling in tumor therapy resistance.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 3, p. 210, doi. 10.1002/cai2.51
- By:
- Publication type:
- Article
Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1387465
- By:
- Publication type:
- Article
Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5665, doi. 10.2147/CMAR.S201513
- By:
- Publication type:
- Article
The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4109, doi. 10.2147/CMAR.S190098
- By:
- Publication type:
- Article
Advancement in research and therapy of NF1 mutant malignant tumors.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01570-8
- By:
- Publication type:
- Article
The role of CD28 in the prognosis of young lung adenocarcinoma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma.
- Published in:
- Molecular Medicine, 2012, v. 18, n. 7, p. 1136, doi. 10.2119/molmed.2012.00055
- By:
- Publication type:
- Article
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-80735-x
- By:
- Publication type:
- Article
Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.574523
- By:
- Publication type:
- Article
Saikosaponin-d suppresses the expression of cyclooxygenase-2 through the phospho-signal transducer and activator of transcription 3/hypoxia-inducible factor-1α pathway in hepatocellular carcinoma cells.
- Published in:
- Molecular Medicine Reports, 2014, v. 10, n. 5, p. 2556, doi. 10.3892/mmr.2014.2574
- By:
- Publication type:
- Article